Forage Hyperfoods produces functional mushroom products and is seeking investor funding. It currently generates revenue through wholesale customers for raw and extracted mushrooms. Forage aims to expand production capacity and inventory to meet increased demand as the functional food market grows. Key milestones for 2021 include launching new product lines, establishing operations in the Caribbean, and formalizing large distribution agreements. Proceeds from funding will be used for operations, sales, increasing inventory, and product expansion. Forage sees potential for significant revenue and market share growth in the functional food and mushroom supplement industries.

1. FORAGE
HYPERFOODS
INVESTOR
DECK
JUNE
2021

2. FORAGE HYPERFOODS INVESTOR DECK JUNE 2021
Market Data
This presentation includes market data and other statistical information from third‐party sources. While the Company believes
these third‐party sources are reliable as of their respective dates, the Company has not independently verified the accuracy or
completeness of this information. Some data are also based on the Company’s estimates, which are derived from both internal
sources and the third‐party sources described above.
General
Capitalized terms used herein that are not otherwise defined have the meanings ascribed to such terms in the preliminary
prospectus. This presentation is being provided by Forage Hyperfoods Inc. (hereinafter “Forage” or “Company”) regarding the
business of Forage. This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the
information contained in the preliminary prospectus. Prospective investors should rely only on the information contained in the
preliminary prospectus. Forage and the Co‐Lead Underwriters have not authorized anyone to provide investors with additional or
different information. Any graphs, tables or other information demonstrating the Company’s historical performance or that of any
other entity contained in the preliminary prospectus or this presentation are intended only to illustrate past performance and are
not necessarily indicative of our or such entities’ future performance. The information contained in this presentation is accurate
only as of the date of this presentation or the date indicated, regardless of the time of delivery of the preliminary prospectus or of
any sale of the Offered Units. No securities regulatory authority has expressed an opinion about the securities described herein
and it is an offence to claim otherwise. The preliminary prospectus constitutes a public offering of securities only in those
jurisdictions where they may be lawfully offered for sale and therein only by persons permitted to sell such securities. The Offered
Units have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities
Act”), or the securities laws of any state of the United States and may not be offered, sold or delivered, directly or indirectly, in
the United States, except pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable
state securities laws. This presentation does not constitute an offer to sell or solicitation of an offer to buy any of the Offered
Shares in the United States. See “Plan of Distribution” in the preliminary prospectus.
All financial disclosures in this presentation are in Canadian dollars, unless otherwise noted.
Risk Factors
The Company is subject to numerous known and unknown uncertainties, risks and other factors that could cause actual results to
differ materially from those set out in this presentation. These factors include, but are not limited to: the impact of the COVID‐19
pandemic and its affect on economies and financial markets; the speculative nature of investment risk; history of operating loss;
limited operating history; negative operating cash flow; going‐concern risk; changes in public tastes, availability of raw materials,
consumer perceptions and preferences, brand awareness and dependency on third party suppliers, distributors and retailers;
dependency on key personnel; product liability and recall; intellectual property risks; research and development; product
obsolescence; anticipated growth may not materialize; dilution; unissued share capital; liquidity and future financing risk; market
risk for securities; and increased costs of being a publicly traded company. Actual results may vary from such forward‐looking
information for a variety of reasons, including but not limited to, risks and uncertainties disclosed in this Prospectus. The
Company cautions that the foregoing list of important risk factors is not exhaustive and other factors could also adversely affect
its business, results or financial condition.
Disclaimer and Cautionary Notes
Forward‐Looking Statements
This presentation contains forward‐looking statements and forward‐looking information (collectively, “forward‐looking
statements”) within the meaning of applicable Canadian securities laws. Forward‐looking statements are statements and
information that are not historical facts but instead represent the Company’s expectations, estimates and projections regarding
future events or circumstances, including financial and market opportunity projections and estimates; statements regarding plans,
goals, objectives, intentions, opportunities and expectations with respect to the Company’s future businesses, operations, growth
and financial results, and other information in future periods. Forward‐looking statements included in this presentation include
statements with respect to the Company’s intentions, beliefs or current expectation concerning, among other things, results of
operations, financial condition, liquidity, prospects, growth, strategies and the industry in which the Company operates.
Forward‐looking statements are statements about the future and are inherently uncertain, and are necessarily based upon a
number of estimates and assumptions that are also uncertain. Certain factors, estimates or assumptions have been applied in
making forward‐looking statements in this presentation, including, but not limited to, that consumer buying patterns will increase
in specialty and grocery stores, that economic conditions in the United States and Canada will continue to show modest
improvement in the near to medium future, that the average cost of mushroom powder will fluctuate in line with historical trends,
that there will be no material change to the competitive environment in the distribution of mushroom‐based food additives and
supplements, that the Company will be able to access sufficient qualified staff, that the Company will be able to develop
distribution channels and a customer base, that there will be no material changes with the Company’s larger customers and that
there will be no material changes to the tax and other regulatory requirements governing the Company.
Forward‐looking statements involve risks and uncertainties, are based on information available at the time such statements are
made, and undue reliance should not be placed on such statements. There is no assurance that any expectations, projections or
goals expressed in any forward‐looking statements will be achieved at all. Forage is under no obligation to update, revise or
confirm this presentation. Corrections and/or changes remain reserved. No representation or warranty, expressed or implied, is
or will be made and no responsibility or liability is or will be accepted by Forage or any of its respective directors, officers,
employees, consultants, agents or affiliates in relation to this presentation. If updates are made to this presentation, there should
be no inference that additional updates will be made.

3. FORAGE HYPERFOODS INVESTOR DECK JUNE 2021
The Future
of Food is Functional
As the wellness economy grows and self-care
emerges as a powerful new value driver for brands,
consumers are shifting their buying decisions to
products emphasizing positive after-effects.
Functional foods aim to solve not only all the needs
that regular foods provide, but also to address
functional needs, which can range from maintaining
and improving physical or mental health to
adjusting energy levels and moods.

4. FORAGE HYPERFOODS INVESTOR DECK JUNE 2021
Reishi’s adaptogenic properties
provide a normalizing effect on the
body to restore normal physiologic
function and protect the body
from stress induced dysfunction.
Turkey Tail mushrooms are rich in
prebiotics, a type of fibre that nourishes
healthy bacteria in the gut to facilitate
improved absorption of nutrients. It is
also rich in antioxidants that combat the
negative effects of oxidative stress, such
as aging and the development of a
range of health conditions.
Lion’s Mane protects and supports the
regeneration of healthy neural pathways
in the brain to combat cognitive
symptoms we associate with aging, like
memory loss and lack of focus.
Chaga
Functional Mushroom Types
Reishi Turkey Tail Lions Mane
Chaga’s immunomodulating properties
support a sluggish immune system to
ward off illness and also work to
suppress hyperactive immune
responses associated with inflammation
and allergies. It is also extremely rich in
antioxidants that protect cells from
oxidative stress caused by free radicals.

5. As a global leading supplier of wild Canadian
Chaga mushrooms and wild harvested functional
mushroom extracts, Forage Hyperfoods has
developed a variety of products and production
techniques to lead the functional mushroom
market into the mainstream.

6. FORAGE HYPERFOODS INVESTOR DECK JUNE 2021
Market Size
$11B
by 2024
*Figures Includes Food & Bev, Pharmaceuticals, Cosmetics, etc. Which
should only be considered as accessible to companies who have the
capability to supply wholesale.
Chaga
Market*
Functional
Food Market
$309B
by 2027
Increasing by
8% CAGR
Functional
Mushroom Market*
$34B
by 2024
Increasing by
14% CAGR
Increasing by
7.5% CAGR

7. This clientele includes fast growing international brands and
co-packers, with the list consistently growing. As market
adoption and expansion continues, the inability for
competitors to mass produce cultivated Chaga coupled with
supply constraints on medicinal mushrooms means we will
directly and indirectly share in the overall growth of the market
and are therefore non-reliant on our direct to consumer lines.
Forage currently has 50+ recurring
wholesale customers for raw and
extracted functional mushrooms.
our growth
market growth =

8. Forage operates with
speed while unlocking
value with gross
margins up to 90%
Vertical Integration allows our product pipeline
to move with speed. This is special in an
industry where supply lines are constrained by
many simultaneous entrants, and reduced
speed of supply due to global or local health
concerns, notably the recent COVID-19 virus.
1. Exclusive network of Foragers & Softbody Harvesters
2. Quebec cleaning and processing facilities
3. Inhouse single and dual extraction production
4. Inhouse extract powder production
5. Inhouse packaging, bottling, capsule filling and labeling
6. JV for production of canned RTD beverages
7. Head office managed ecommerce based retail and wholesale
storefront
Vertical Integration &
Supply Security
Confidential Draft

9. From 4 to 15 to over 30 SKU’s in 2021,
we meet our customers where they are
with a variety of consumption methods.
With the strategic acquisition of Chaga.ca,
investment in extraction technology and
rebanding, Forage Hyperfoods has solidified
a head start with strong revenue base and
has barriers to entry strongly in place versus
competitors.
Brand Evolution
2020 2021, Q1 2021, Q2 2021, Q3
Proprietary Extraction Methods

10. Forage as an Entry
to Mushrooms &
Gateway to Psychedelics

11. Backpack Co. (Pre-Launch)
www.bkpk.co/
@bkpk.co
Forage has 25% equity in exchange for advisory
and supply with ready to drink functional
beverage backpack™. backpack™ provides
customers with a transformative collection of
mushroom-based tonics that were expertly
crafted right here in North America. backpack™
separates itself from competitors with a safe line
of products that are as accessible as they are
adaptable, and designed to align with the lifestyle
of any and every consumer.

12. Ticket Microdose (Pre-launch)
www.ticketmd.co/
@ticketmd.co
Ticket (wholly-owned subsidiary) is a ready to
deploy brand that will offer natural psilocybin
psychedelic microdose products in the most
popular methods of consumption. From
chocolates and gummies to RTD beverages, if
a customer is looking to take a trip, they’ll be
sure to get their Ticket from us.
Beginning with legal markets (Bahamas and
Jamaica), we have a clear path to market ready
products within 12 months and currently in
discussions with a world renowned local
producer of edible products.

13. Co-Founders
Jonathan Murray
President & Co-Founder
Jonathan has firmly established himself as an executor. He has an
extensive background in building and leading sales and marketing
teams for national and international companies. Prior to launching
Forage Hyperfoods, Jonathan was a VP and Partner at a digital
marketing agency and spent 7 years as a top sales representative
for Stryker in the competitive industry of MedTech. Running the
Greater Toronto Area territory he achieved various sales awards
for competitive conversions and highest annual sales revenue.
Before med-tech, he lead the rebranding of Senstar Corp., a
Defence tech company and opened the South American market
for Clearford Industries closing their first paid international sale.
Christopher Murray, Co-Founder
Chris is the Principal Strategist for FoxNRTH Inc. a boutique
shop providing business, regulatory & strategic consulting.
Chris was one of the founding employees of Canopy Growth
Corporation, notably Chris was responsible for securing and
leading the development of Houseplant within CGC and
successfully facilitating the export of Cannabis from Canada
to the USA. In April 2021, Chris successfully facilitated he
import of psilocybin into the USA for Wake Network.
Shane Currey, Co-Founder
Shane has invested, advised, mentored, and strategically
partnered with over a dozen companies in his career in
finance. Recently featured in Forbes Magazine, Shane’s
assistance in aiding the success of companies he partners
with has been widely noted internationally. With Shane’s
involvement, his portfolio of companies’ upside has
achieved over $1 billion in growth.
Chanel Murray, VP & Co-Founder
Chanel has experience in branding, retail and retail
operations management. She began her career with Inditex
sub-brand Zara as a fashion merchandising associate and
sale consultant. She then spent 6 years as a full-time flight
attendant with Air Canada while running Rush Studio, a
freelance fashion and branding studio. Chanel’s most recent
role was as the Assistant Manager at Frank & Oak’s flagship
retail store in Canada’s busiest retail mall, the Eaton Centre.
David Ewart, CPA, CA - CFO
David is a Chartered Accountant with over fifteen years of
broad-based experience as Chief Financial Officer (CFO) in the
Aerospace, Defense, Manufacturing, and High Tech sectors. David
has also spent more than five years as a financial consultant in the
private sector. Throughout David’s 30 year career, he has worked
across 18 industries and assisted in raising over $120 million
dollars for early stage companies.

14. Advisory Board
Josh Campbell
Advisor - Branding,
CPG & Retail
Dosist, Saje Wellness, Human
Improvement, Starbucks
Dante Simpson
Advisor - Media and Partnership
ESPAT.TV, Sony, Gucci, NFL, Travis
Scott, Post Malone
Jessica Hay
Advisor - Branding & Design
Tweed, Bedrocan, Tokyo
Smoke, Drake, Snoop
Dogg, Martha Stewart
Martin Aquilina
Advisor - Tax, Regulatory &
International Law
HazloLaw Business Lawyers
Ryan O’Connor
Advisor - eCommerce &
Product Development
EDealer, EBlock,
Unreserved.com
David Seal
Advisor - eCommerce &
Product Development
Shopify, Select Start
Studios

15. Comparable Companies
Company Food & Bev Supplement Psych
Proprietary
Supply Chain
2020 Reported
Revenues
Market Cap (CAD)
As of 12:00 - 06-15-2021
✓ 🚫 🚫 🚫 $23,000,000 $345,230,000
✓ 🚫 🚫 🚫 $50m- $60m (Private) $400m-$1b?
✓ ✓ 🚫 🚫 $0 $47,970,000
✓ 🚫 ✓ ✓ $173,000 $112,000,000
🚫 ✓ ✓ ✓ $0 $49,000,000
✓ ✓ ✓ ✓
$350,000*
*pre-acquisition
$25,000,000

16. 2021 Key Milestones
Distribution agreements to
bring Forage into
nationwide retail outlets in
2022
BackPack GTM for
mushroom stack shots, RTD
beverages
Closed seed round
and the acquisition
of Chaga.ca + 15
other URL’s in
addition to their
production facility
and operational
assets
Added reishi, turkey tail, and
lion’s mane mushrooms to
our product offering. secured
exclusive rights of product
from additional suppliers,
doubling our output capacity.
2nd location opens, with
state of the art production
technology
Launch of additional
mushroom tincture lines,
quadrupling product offering
Brand & eCommerce
launch
Launch of Out of the Woods
mushroom coffee line in bags,
KCups and Nespresso format
Launch of Made in the Shade
mushroom based herbal tea
blends in 4 unique varieties
Establishment of Subsidiary in
the Caribbean to begin
operations of a legal
recreational psychedelic
brand.
February March April May
June July/August September Q4

17. Use of Proceeds ● Operations, production and sales staff
● Retainer and upfront sales costs associated with formalizing
distribution agreements with US and ultimately global partners
Staffing & Sales
● Increase harvest yield to ensure substantial stock of products
in advance of B2C & B2B sales push
● Purchase of equipment to scale up production upon
commencement of B2B supply deals
Inventory & Product Expansion
● Continuous refinement of digital marketing assets to appeal to
multiple demographics, and ensure high performing digital ads
● With a positive ROAS and climbing Lifetime Value of our
Customer Base, we can scale up add spend to grow our consumer
base and recurring revenues
Marketing & Ad Spend
● Establishment of our premium microdose product and brand
across federally legal markets of Bahamas & Jamaica
● Exploration of licensing agreements with local producers in
US jurisdictions with state legalization
Ticket Microdose Co.

18. Thank you.
Contact: jon@chaga.ca